Optimum dose of aspirin for patients with heart disease
6366 Wedgeview CT, Tucker, GA, 30084, USA.
Research Article
International Journal of Frontiers in Biology and Pharmacy Research, 2022, 03(02), 017–019.
Article DOI: 10.53294/ijfbpr.2022.3.2.0062
Publication history:
Received on 14 October 2022; revised on 29 November 2022; accepted on 01 December 2022
Abstract:
A 10-year study on a human subject showed that the optimum dose of aspirin to treat coronary heart disease was about 49 mg daily. If the dose was increased to 56 mg, insignificant and reversible hematuria would occur. If the dose was decreased to 40.5 mg, inadequate efficacy would result. No kidney problem was observed as long as the dose did not exceed 56 mg. These findings are a good supplement to the FDA’s recent new guidance on how to use this medication safely to prevent stroke and heart attack.
Keywords:
Aspirin; Optimum dose; Heart disease; Hematuria
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0